FDA Drug Recalls

Recalls / Class II

Class IID-1530-2014

Product

Lipo 8 Injection USP 200 mg/ml, packaged in 30 ml vials, Sterile, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.

Affected lot / code info
All lot numbers and exp dates

Why it was recalled

Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer

Recalling firm

Firm
Medical Supply Liquidators Llc
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
10500 Hickman Rd Ste F, N/A, Clive, Iowa 50325-3706

Distribution

Quantity
N/A
Distribution pattern
Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.

Timeline

Recall initiated
2014-06-25
FDA classified
2014-08-06
Posted by FDA
2014-08-13
Terminated
2017-03-14
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1530-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls